Professor Hirohide Saito and his research team have developed a new microRNA-responsive hybrid mRNA switch, enabling precise, ...

Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...

The elephant vaccine closely resembles other mRNA vaccines made for humans. mRNA packed in lipid nanoparticles carries ...

Institutions like OMRF have had almost unbroken bipartisan support as a national biomedical research policy. Breaking it would be irreversibly tragic.

If we don’t invest in technologies like mRNA vaccines for pandemic influenza now, once a virus starts going human-to-human, ...

The biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial.

When the COVID-19 pandemic swept across the world in 2020, the mRNA vaccines came to the rescue of many people—but in the ...

The promise of mRNA technology seemed boundless after the success of the coronavirus vaccines, but Robert F. Kennedy Jr. has singled it out for scrutiny, clouding its prospects.

The author says the action creates mistrust of the committee’s vaccine recommendations and further increases patients’ and ...

The Trump administration is eroding national pandemic flu defenses as it guts health agencies, cuts research and health ...

Scientists have long-known that mRNA could hold the key to developing much-needed vaccines. The covid pandemic proved them right, spurring a boom in mRNA-based vaccine research that could soon ...

In adults 50 and older, Moderna’s flu shot was more than 26% better than an unspecified commercial vaccine. In May, the ...